Metharbital drug data and news

Metharbital drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Metharbital
Brand Names/Synonyms AN 23; CHEMBANK2962; Endiemal; Endiemalum; Gemonal; Gemonil; Gemonit; Metabarbital; Metarbital [Inn-Spanish]; Metarbitale [Dcit]; Methabarbital; Methabarbitone; Metharbital; Metharbital [Inn:Jan]; Metharbitalum [Inn-Latin]; Metharbitone; Metharbutal; Methylbarbital; N-Methylbarbital; Sch 412
Indication For the treatment of epilepsy
Sponsored links
Description Not Available
Pharmacology Metharbital, a barbiturate, is used for the treatment of short term insomnia. It belongs to a group of medicines called central nervous system (CNS) depressants that induce drowsiness and relieve tension or nervousness. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Mechanism Of Action Metharbital binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. All of these effects are associated with marked decreases in GABA-sensitive neuronal calcium conductance (gCa). The net result of barbiturate action is acute potentiation of inhibitory GABAergic tone. Barbiturates also act through potent (if less well characterized) and direct inhibition of excitatory AMPA-type glutamate receptors, resulting in a profound suppression of glutamatergic neurotransmission.
Metharbital News
(When available)
[an error occurred while processing this directive]
Dosage Forms TABLET
Drug_Category Anticonvulsants; ATC:N03AA30
Absorption Not Available
Interactions Interactions for Metharbital:
Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives (birth control pills) containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
Toxicity Signs of overdose include confusion (severe); decrease in or loss of reflexes; drowsiness (severe); fever; irritability (continuing); low body temperature; poor judgment; shortness of breath or slow or troubled breathing; slow heartbeat; slurred speech; staggering; trouble in sleeping; unusual movements of the eyes; weakness (severe).
Organisms Affected Humans and other mammals
Chemical IUPAC Name 5,5-diethyl-1-methyl-hexahydropyrimidine-2,4,6-trione
Chemical Formula C9H14N2O3
Molecular Weight 198.219 g/mol
Smiles String CCC1(C(=O)NC(=O)N(C1=O)C)CC
Melting Point 150.5 °C
Water Solubility 1980 mg/L
State Solid
LogP/Hphobicity 1.051
Isoelectric Point 8.01
Biotransformation Not Available
Half Life Not Available
Protein Binding [%] Not Available
RxList Link Not Available>RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Metharbital.html
Drug Type Approved Drug
Accession No APRD00757
CAS Registry Number 50-11-3
KEGG Compound ID C12820
PubChem ID SID:583209
PharmGKB ID PA450412
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] Not Available

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org